Nikko Asset Management Americas Inc. Lowers Position in Accolade, Inc. (NASDAQ:ACCD)

Nikko Asset Management Americas Inc. lessened its holdings in Accolade, Inc. (NASDAQ:ACCD - Free Report) by 6.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,766,480 shares of the company's stock after selling 120,531 shares during the period. Nikko Asset Management Americas Inc. owned about 2.17% of Accolade worth $6,024,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Rhumbline Advisers grew its holdings in shares of Accolade by 1.7% during the 4th quarter. Rhumbline Advisers now owns 115,136 shares of the company's stock valued at $394,000 after purchasing an additional 1,967 shares during the last quarter. Centiva Capital LP grew its stake in shares of Accolade by 5.8% during the third quarter. Centiva Capital LP now owns 59,660 shares of the company's stock worth $230,000 after buying an additional 3,264 shares during the last quarter. Mission Creek Capital Partners Inc. acquired a new position in shares of Accolade during the third quarter worth $38,000. Inspire Investing LLC lifted its stake in shares of Accolade by 9.9% in the 4th quarter. Inspire Investing LLC now owns 117,216 shares of the company's stock valued at $401,000 after acquiring an additional 10,537 shares during the last quarter. Finally, SG Americas Securities LLC boosted its holdings in shares of Accolade by 36.1% during the 4th quarter. SG Americas Securities LLC now owns 40,498 shares of the company's stock valued at $139,000 after acquiring an additional 10,749 shares in the last quarter. Institutional investors and hedge funds own 84.99% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Piper Sandler downgraded Accolade from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Stifel Nicolaus reissued a "hold" rating and set a $7.03 target price (down from $8.00) on shares of Accolade in a report on Thursday, January 9th. Canaccord Genuity Group reaffirmed a "hold" rating on shares of Accolade in a research note on Wednesday, January 8th. Stephens reissued an "equal weight" rating and issued a $7.03 price objective on shares of Accolade in a research note on Wednesday, February 12th. Finally, Morgan Stanley decreased their price objective on Accolade from $6.00 to $5.00 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. Thirteen analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $6.51.

Accolade Trading Up 0.3 %

Shares of NASDAQ:ACCD traded up $0.02 during mid-day trading on Friday, hitting $7.01. The company had a trading volume of 1,322,583 shares, compared to its average volume of 1,394,584. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.63 and a quick ratio of 2.63. Accolade, Inc. has a one year low of $3.08 and a one year high of $10.68. The firm has a fifty day moving average price of $6.92 and a 200 day moving average price of $4.84. The company has a market capitalization of $574.77 million, a PE ratio of -3.12 and a beta of 2.18.

Accolade (NASDAQ:ACCD - Get Free Report) last announced its quarterly earnings data on Friday, January 10th. The company reported ($0.30) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.01. Accolade had a negative net margin of 40.36% and a negative return on equity of 20.74%. As a group, research analysts forecast that Accolade, Inc. will post -1.2 EPS for the current year.

About Accolade

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians.